Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice
about
15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancersMolecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldLoss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expressionLipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancerInflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathwaysThe Role of Chemokines in Promoting Colorectal Cancer Invasion/MetastasisEicosanoid pathway in colorectal cancer: Recent updatesCyclooxygenase-2 promotes tumor growth and suppresses tumor immunityThe Hen or the Egg: Inflammatory Aspects of Murine MPN ModelsEicosanoid profiling in colon cancer: emergence of a patternEpigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequencesThe role of the EP receptors for prostaglandin E2 in skin and skin cancerCyclooxygenase-2 and gastric carcinogenesisProstaglandins and cancerInflammation and cancer, the mastocytoma P815 tumor model revisited: triggering of macrophage activation in vivo with pro-tumorigenic consequencesOvarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progressionHigh MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival timeDiscovering chemical modifiers of oncogene-regulated hematopoietic differentiationActivated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells.Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.Novel insights into G protein and G protein-coupled receptor signaling in cancerProstaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotectionMicrosomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis.Chronic cyclooxygenase-2 inhibition promotes myofibroblast-associated intestinal fibrosis.PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis.Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccines.Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesis.Eicosanoids and cancerGenetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family RegistryThe connectivity map links iron regulatory protein-1-mediated inhibition of hypoxia-inducible factor-2a translation to the anti-inflammatory 15-deoxy-delta12,14-prostaglandin J2Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastoma.Cellular arachidonate-releasing function of novel classes of secretory phospholipase A2s (groups III and XII).The {omega}-3 fatty acid eicosapentaenoic acid elicits cAMP generation in colonic epithelial cells via a "store-operated" mechanism.Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis.Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.The role of adiponectin in cancer: a review of current evidence.Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities.
P2860
Q24318523-E878F3B4-D543-49FE-9A68-5C1CFA8F497BQ24620628-23B01964-247E-4107-A41E-A30CEF3414B9Q24684962-ADB0EBE6-92B3-4145-81D3-79E4756A57E0Q24800010-B172721E-2E09-4291-94BB-175082E01139Q26748123-A6726118-B7D0-4BC3-AB6C-920DEAFE59F4Q26748194-2AC79E7C-C2DE-4C2B-97CB-B55E63E5B2CDQ26778011-A4C92319-8E46-40F1-97CA-2FD982CF371CQ26778534-A790CD1E-5D87-4C90-84FA-3C3F98806C32Q26778931-8DE26DDD-7531-45F9-BB85-9C65DCF259DBQ26859889-E68AA6B4-D42F-44F5-804F-B0AD596ACEC2Q26862642-E6856900-7A5A-4633-98DF-807F8CF464DEQ26999707-AA62189C-ECAD-48B7-9FE6-AB8C6B63210FQ28184447-0E6A001E-1053-4788-A4E1-E27D4DF21D51Q28188827-0C580652-78E2-4FC8-96F5-4EF09040056CQ28193430-3451DF2E-9DB3-42C2-B439-0968743D42CFQ28210448-ADAF899D-EC73-4326-9E7A-7C293DA0AB8CQ28536347-28079987-C7C6-4A8C-B4E1-DAA259EEB927Q30438385-2E94BFBF-3F36-4AF5-82C0-49210CAA3C80Q30482206-03D8003D-63DE-4192-B557-AFF419CD31DEQ33475171-A3F52E84-6EA9-4858-BF82-5E230868BA62Q33555154-6649D7BF-E9C3-49DD-99A4-DFDF50F10EAEQ33612895-F319A6E6-543F-48C4-B3E6-0C0D3432859DQ33651797-475FCC6E-97A8-449A-93C0-97FA3DA70AD3Q33675073-4094BA91-6804-413F-9371-78859EA879B0Q33708065-97B2588C-96DC-4DD3-86CF-0B5511E3DAB9Q33723499-A9C81E6D-2FDA-4C3B-904B-D098F8B4B280Q33752909-9F7B349D-38A9-49C8-A1FB-CC87A885CDDFQ33754989-544886EA-0F29-4EFB-B600-155DD50D8E8FQ33770260-BE4C7042-4D31-473D-B89B-F2D227E94201Q33799761-CBF13ACB-3AC4-4809-9975-188AC1E5ADCCQ33966203-D47CC2DB-A02D-4CA7-B6CA-BDC3C3663F11Q34096843-ACBA3E50-8CAE-47B9-9282-C8EB044EAB04Q34107535-4B67B251-F377-41B6-A74A-97A4BB03D119Q34140169-11E66832-D3E3-4045-973D-DCD357901F20Q34169715-DBD158C5-F279-4B7C-BE89-CABC1FE8D1D3Q34178830-3E2AF5D7-5146-4A6D-A6DD-A25B4D41E9C3Q34182494-0287412D-79CF-4198-803F-1F8B03CC7783Q34211385-E88A1328-01EF-4700-8354-056188C21802Q34271986-97C40B2D-EB6F-4F9B-8B4C-9C9B9CBE9FE5Q34279863-CDC2AB90-0699-4635-983D-7E068641D9B8
P2860
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice
description
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im September 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/09/01)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/09/01)
@nl
наукова стаття, опублікована у вересні 2001
@uk
مقالة علمية (نشرت في سبتمبر 2001)
@ar
name
Acceleration of intestinal pol ...... n Apc(Delta 716) knockout mice
@ast
Acceleration of intestinal pol ...... n Apc(Delta 716) knockout mice
@en
Acceleration of intestinal pol ...... n Apc(Delta 716) knockout mice
@nl
type
label
Acceleration of intestinal pol ...... n Apc(Delta 716) knockout mice
@ast
Acceleration of intestinal pol ...... n Apc(Delta 716) knockout mice
@en
Acceleration of intestinal pol ...... n Apc(Delta 716) knockout mice
@nl
prefLabel
Acceleration of intestinal pol ...... n Apc(Delta 716) knockout mice
@ast
Acceleration of intestinal pol ...... n Apc(Delta 716) knockout mice
@en
Acceleration of intestinal pol ...... n Apc(Delta 716) knockout mice
@nl
P2093
P921
P3181
P356
P1433
P1476
Acceleration of intestinal pol ...... n Apc(Delta 716) knockout mice
@en
P2093
Narumiya S
Sonoshita M
Sugimoto Y
Ushikubi F
P2888
P304
P3181
P356
10.1038/NM0901-1048
P407
P577
2001-09-01T00:00:00Z